Next Article in Journal
Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview
Next Article in Special Issue
Does Unidirectional Block Exist after a Radiofrequency Line Creation? Insights from Ultra-High-Density Mapping (The UNIBLOCK Study)
Previous Article in Journal
Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome
Review

Clinical Evidence behind Stereotactic Radiotherapy for the Treatment of Ventricular Tachycardia (STAR)—A Comprehensive Review

1
IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland
2
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, 40-055 Katowice, Poland
3
International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne’s University Hospital Brno, 664/53 Brno, Czech Republic
4
Upper-Silesian Heart Center, Department of Electrocardiology, 40-055 Katowice, Poland
5
Department of Electrocardiology and Heart Failure, Medical University of Silesia, 40-055 Katowice, Poland
6
First Department of Cardiology, Medical University of Silesia, 40-055 Katowice, Poland
7
Department of Electrocardiology, John Paul II Hospital, 31-202 Cracow, Poland
8
Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland
*
Author to whom correspondence should be addressed.
Academic Editor: Mariusz Kowalewski
J. Clin. Med. 2021, 10(6), 1238; https://doi.org/10.3390/jcm10061238
Received: 18 February 2021 / Revised: 14 March 2021 / Accepted: 15 March 2021 / Published: 17 March 2021
(This article belongs to the Special Issue Cardiac Ablation - Current Practice and Future Trends)
The electrophysiology-guided noninvasive cardiac radioablation, also known as STAR (stereotactic arrhythmia radioablation) is an emerging treatment method for persistent ventricular tachycardia. Since its first application in 2012 in Stanford Cancer Institute, and a year later in University Hospital Ostrava, Czech Republic, the authors from all around the world have published case reports and case series, and several prospective trials were established. In this article, we would like to discuss the available clinical evidence, analyze the potentially clinically relevant differences in methodology, and address some of the unique challenges that come with this treatment method. View Full-Text
Keywords: ablation; noninvasive; radiosurgery; stereotactic body radiation therapy; substrate ablation; ventricular tachycardia ablation; noninvasive; radiosurgery; stereotactic body radiation therapy; substrate ablation; ventricular tachycardia
Show Figures

Figure 1

MDPI and ACS Style

Miszczyk, M.; Jadczyk, T.; Gołba, K.; Wojakowski, W.; Wita, K.; Bednarek, J.; Blamek, S. Clinical Evidence behind Stereotactic Radiotherapy for the Treatment of Ventricular Tachycardia (STAR)—A Comprehensive Review. J. Clin. Med. 2021, 10, 1238. https://doi.org/10.3390/jcm10061238

AMA Style

Miszczyk M, Jadczyk T, Gołba K, Wojakowski W, Wita K, Bednarek J, Blamek S. Clinical Evidence behind Stereotactic Radiotherapy for the Treatment of Ventricular Tachycardia (STAR)—A Comprehensive Review. Journal of Clinical Medicine. 2021; 10(6):1238. https://doi.org/10.3390/jcm10061238

Chicago/Turabian Style

Miszczyk, Marcin, Tomasz Jadczyk, Krzysztof Gołba, Wojciech Wojakowski, Krystian Wita, Jacek Bednarek, and Sławomir Blamek. 2021. "Clinical Evidence behind Stereotactic Radiotherapy for the Treatment of Ventricular Tachycardia (STAR)—A Comprehensive Review" Journal of Clinical Medicine 10, no. 6: 1238. https://doi.org/10.3390/jcm10061238

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop